The image-guided therapy systems market size is expected to see strong growth in the next few years. It will grow to $6.95 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to growth in telemedicine adoption, integration with AI-driven analytics, rising geriatric population, expansion of homecare infrastructure, increasing consumer preference for personalized health monitoring. Major trends in the forecast period include remote sleep monitoring, personalized sleep health insights, integration with wearable health devices, data-driven sleep disorder diagnosis, home-based patient care adoption.
The increasing preference for minimally invasive surgeries is anticipated to drive the expansion of the image-guided therapy systems market in the coming years. Minimally invasive surgeries utilize surgical methods that minimize the size and number of incisions, thereby reducing patient trauma and shortening recovery periods. The rising popularity of these surgeries is mainly attributed to their advantages of faster recovery, as smaller incisions cause less tissue damage and enable patients to resume normal activities more quickly than traditional open surgeries. Image-guided therapy systems facilitate minimally invasive surgeries by providing real-time imaging, allowing surgeons to precisely navigate instruments and target treatment areas while preserving healthy surrounding tissue. For example, in February 2024, the American Academy of Facial Plastic and Reconstructive Surgery, a US-based non-profit organization, reported that in 2023, minimally invasive procedures accounted for 83% of all medical procedures performed, with traditional surgeries making up the remaining 17%. Consequently, the rising demand for minimally invasive surgeries is fueling the growth of the image-guided therapy systems market.
Key players in the image-guided therapy systems market are concentrating on innovative technologies such as 3D imaging solutions to improve diagnostic accuracy, enhance procedural efficiency, and enable precise, minimally invasive treatments that lead to better patient outcomes. 3D imaging solutions create detailed three-dimensional visualizations of internal body structures, allowing healthcare professionals to examine anatomy with improved depth and clarity. For instance, in February 2024, Koninklijke Philips N.V., a Netherlands-based healthcare technology firm, introduced its Azurion neuro biplane image-guided therapy system at the European Congress of Radiology (ECR) 2024. The system offers enhanced 2D and 3D imaging, automated beam rotation for optimal image orientation, advanced C-arm angulation and rotation, and comprehensive table-side controls to maintain a sterile environment. It also features a head immobilizer for improved stroke care and flexible X-ray detector positioning. Integrated with Philips’ ClarityIQ low-dose imaging technology and neuro suite software, this system highlights Philips’ focus on improving workflow efficiency, clinical decision-making, and patient outcomes in neurovascular procedures.
In October 2023, GE HealthCare Technologies Inc., a US-based medical technology firm, collaborated with Boston Scientific Corporation to integrate the AVVIGO+ Multi-Modality Guidance System with its Allia IGS Pulse platform, aiming to streamline interventional cardiology workflows. Through this collaboration, GE HealthCare and Boston Scientific seek to allow interventional cardiologists to manage multiple third-party devices via a single interface, enhance multimodality guidance, and boost procedural efficiency. Boston Scientific Corporation is a US-based medical device company that focuses on delivering interventional cardiovascular solutions.
Major companies operating in the image-guided therapy systems market are Medtronic plc, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Zimmer Biomet Holdings Inc., Olympus Corporation, Smith & Nephew plc, Hologic Inc., Shimadzu Corporation, KARL STORZ SE & Co. KG, Cook Medical LLC, Elekta AB, Leica Microsystems GmbH, Brainlab AG, Analogic Corporation, Hyperfine Inc., Quest Medical Imaging B.V.
North America was the largest region in the image-guided therapy systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the image-guided therapy systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the image-guided therapy systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the home sleep screening devices market by increasing the cost of imported electronic components and wearable sensors, leading to higher manufacturing expenses. The impact is particularly notable in regions like North America and Europe where reliance on imports for high-precision sensors is significant. Non-wearable bedside monitors and under-mattress sensors are among the segments most affected, while smartphone applications face moderate effects due to software-driven solutions. On the positive side, tariffs have encouraged some manufacturers to localize production and invest in domestic R&D, potentially fostering innovation and reducing future dependency on imports.
The image-guided therapy systems market research report is one of a series of new reports that provides image-guided therapy systems market statistics, including image-guided therapy systems industry global market size, regional shares, competitors with a image-guided therapy systems market share, detailed image-guided therapy systems market segments, market trends and opportunities, and any further data you may need to thrive in the image-guided therapy systems industry. This image-guided therapy systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Image-guided therapy systems are sophisticated medical technologies that utilize real-time imaging to assist and oversee therapeutic procedures. These systems enable physicians to accurately locate, target, and treat specific areas within the body, thereby enhancing precision and reducing harm to surrounding healthy tissues. This leads to improved treatment outcomes and fewer complications.
The primary types of image-guided therapy systems include ultrasound devices, endoscopes, magnetic resonance imaging (MRI) machines, X-ray fluoroscopy or C-arms, positron emission tomography (PET), single-photon emission computed tomography (SPECT), and others. Ultrasound systems employ high-frequency sound waves to generate real-time, radiation-free images of internal organs, guiding minimally invasive procedures. These systems incorporate technologies such as electromagnetic navigation, robotic-assisted imaging guidance, AI-enhanced real-time 3D or 4D imaging, augmented or mixed-reality visualization, and optical and laser-based tracking. They are categorized by portability into fixed systems, mobile C-arms, and handheld or portable units. Applications span cardiac surgery, neurosurgery, orthopedic surgery, gastroenterology, urology, oncology, ENT surgery, and more. The main users include hospitals, ambulatory surgical centers, specialty clinics, and research and academic institutions.
The image-guided therapy systems market consists of revenues earned by entities by providing services such as real-time imaging and navigation support, treatment planning and simulation, intraoperative imaging integration, system installation and maintenance, training and education services. The market value includes the value of related goods sold by the service provider or included within the service offering. The image-guided therapy systems market also includes sales of image-guided surgical navigation systems, robotic-assisted surgical systems, laser-based imaging systems, optical coherence tomography (OCT) systems, intraoperative imaging systems, and gamma cameras, infrared imaging systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Image-Guided Therapy Systems Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses image-guided therapy systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for image-guided therapy systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The image-guided therapy systems market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Ultrasound Systems; Endoscopes; Magnetic Resonance Imaging (MRI); X-Ray Fluoroscopy Or C-Arms; Positron Emission Tomography (PET); Single-Photon Emission CT (SPECT); Other Product Types2) By Technology: Electromagnetic Navigation; Robotic-Assisted Imaging Guidance; Artificial Intelligence (AI)-Enhanced Real-Time 3D Or 4D Imaging; Augmented Or Mixed-Reality Visualization; Optical And Laser-Based Tracking
3) By Modality Portability: Fixed Systems; Mobile C-Arms; Hand-Held Or Portable
4) By Application: Cardiac Surgery; Neurosurgery; Orthopedic Surgery; Gastroenterology; Urology; Oncology; Ear, Nose, And Throat Surgery; Other Applications
5) By End Use: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Research And Academic Institutions
Subsegments:
1) By Ultrasound Systems: Two-Dimensional (2D) Ultrasound Systems; Three-Dimensional (3D) And Four-Dimensional (4D) Ultrasound Systems; Doppler Ultrasound Systems; Contrast-Enhanced Ultrasound Systems; Portable and Handheld Ultrasound Devices2) By Endoscopes: Rigid Endoscope Systems; Flexible Endoscope Systems; Image-Guided Therapeutic Endoscope Systems; Robot-Assisted Endoscopic Systems; Single-Use (Disposable) Endoscope Systems
3) By Magnetic Resonance Imaging (MRI): Open Magnetic Resonance Imaging Systems; Closed Magnetic Resonance Imaging Systems; Interventional MRI Systems; 1.5 Tesla Magnetic Resonance Imaging Systems; 3 Tesla Magnetic Resonance Imaging Systems; Intraoperative Magnetic Resonance Imaging (iMRI) Systems
4) By X-Ray Fluoroscopy or C-Arms: Mobile C-Arm Imaging Systems; Mini C-Arm Imaging Systems; Fixed C-Arm Imaging Systems; Flat Panel Detector C-Arm Systems; Image Intensifier C-Arm Systems
5) By Positron Emission Tomography (PET): Positron Emission Tomography-Computed Tomography (PET-CT) Systems; Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI) Systems; Time-Of-Flight (TOF) Positron Emission Tomography Systems; Digital Positron Emission Tomography Systems
6) By Single-Photon Emission Computed Tomography (SPECT): Standalone Single-Photon Emission Computed Tomography Systems; Hybrid Single-Photon Emission Computed Tomography Or Computed Tomography Systems; Multi-Head Single-Photon Emission Computed Tomography Systems; Cardiac Single-Photon Emission Computed Tomography Systems
7) By Other Product Types: Computed Tomography (CT) Imaging Systems; Optical Imaging Systems; Photoacoustic Imaging Systems; Hybrid Operating Room Systems; Gamma Camera Imaging Systems
Companies Mentioned: Medtronic plc; Siemens Healthcare GmbH; FUJIFILM Holdings Corporation; Koninklijke Philips N.V.; Stryker Corporation; GE HealthCare Technologies Inc.; Boston Scientific Corporation; Zimmer Biomet Holdings Inc.; Olympus Corporation; Smith & Nephew plc; Hologic Inc.; Shimadzu Corporation; KARL STORZ SE & Co. KG; Cook Medical LLC; Elekta AB; Leica Microsystems GmbH; Brainlab AG; Analogic Corporation; Hyperfine Inc.; Quest Medical Imaging B.V.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Image-Guided Therapy Systems market report include:- Medtronic plc
- Siemens Healthcare GmbH
- FUJIFILM Holdings Corporation
- Koninklijke Philips N.V.
- Stryker Corporation
- GE HealthCare Technologies Inc.
- Boston Scientific Corporation
- Zimmer Biomet Holdings Inc.
- Olympus Corporation
- Smith & Nephew plc
- Hologic Inc.
- Shimadzu Corporation
- KARL STORZ SE & Co. KG
- Cook Medical LLC
- Elekta AB
- Leica Microsystems GmbH
- Brainlab AG
- Analogic Corporation
- Hyperfine Inc.
- Quest Medical Imaging B.V.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.47 Billion |
| Forecasted Market Value ( USD | $ 6.95 Billion |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |


